Lupin gets FDA approval for Vibra-Tabs generic

SILVER SPRING, Md. — The Food and Drug Administration has approved Lupin’s generic of Pfizer’s Vibra-Tabs (doxycycline hyclate) tablets. The drug is indicatd to treat infections caused by various microorganisms and as an adjunctive therapy for severe acne.

Lupin’s generic will be available in 100-mg dosage strength. The drug had U.S. sales of $149.9 million for the 12 months ended June 2017, according to QuintilesIMS data.